GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurisco Pharmaceutical Co Ltd (SHSE:605116) » Definitions » Pre-Tax Income

Aurisco Pharmaceutical Co (SHSE:605116) Pre-Tax Income : ¥450 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Aurisco Pharmaceutical Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Aurisco Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ¥142 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥450 Mil. Aurisco Pharmaceutical Co's pretax margin was 35.21%.

During the past 9 years, Aurisco Pharmaceutical Co's highest Pretax Margin was 35.47%. The lowest was 12.86%. And the median was 25.75%.


Aurisco Pharmaceutical Co Pre-Tax Income Historical Data

The historical data trend for Aurisco Pharmaceutical Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurisco Pharmaceutical Co Pre-Tax Income Chart

Aurisco Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only 185.74 192.01 240.75 329.08 407.39

Aurisco Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.11 117.26 108.21 82.81 141.54

Competitive Comparison of Aurisco Pharmaceutical Co's Pre-Tax Income

For the Biotechnology subindustry, Aurisco Pharmaceutical Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurisco Pharmaceutical Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aurisco Pharmaceutical Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Aurisco Pharmaceutical Co's Pre-Tax Income falls into.


;
;

Aurisco Pharmaceutical Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Aurisco Pharmaceutical Co's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=412.162+0+-15.778+14.943+-3.9349999999999
=407

Aurisco Pharmaceutical Co's Pretax Income for the quarter that ended in Mar. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=144.426+0+-8.154+2.186+3.078
=142

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥450 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurisco Pharmaceutical Co  (SHSE:605116) Pre-Tax Income Explanation

Aurisco Pharmaceutical Co's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=141.536/401.995
=35.21%

During the past 9 years, Aurisco Pharmaceutical Co's highest Pretax Margin was 35.47%. The lowest was 12.86%. And the median was 25.75%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurisco Pharmaceutical Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Aurisco Pharmaceutical Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurisco Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Badu Industrial Park, Tiantai County, Zhejiang Province, Taizhou, CHN, 317200
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
Executives
Qiu Pei Jing Director
Zhao Zhen Ping senior management
Zhang Li Qin senior management

Aurisco Pharmaceutical Co Headlines

No Headlines